Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
89Bio Inc
(NQ:
ETNB
)
9.220
+0.360 (+4.06%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about 89Bio Inc
< Previous
1
2
3
4
5
Next >
AVEO Pharmaceuticals, Akouos And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
October 18, 2022
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
September 16, 2022
Via
Benzinga
Analyst Ratings for 89bio
September 14, 2022
Over the past 3 months, 7 analysts have published their opinion on 89bio (NASDAQ:ETNB) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's...
Via
Benzinga
7 Analysts Have This to Say About 89bio
September 14, 2022
89bio (NASDAQ:ETNB) has observed the following analyst ratings within the last quarter:
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 13, 2022
Via
Benzinga
89bio's Pegozafermin Data Shows Improved Liver Fat, Glycemic Control
August 26, 2022
Via
Benzinga
Analysts Are Bullish On 89bio's NASH Data Slated For Early Next Year
August 18, 2022
Via
Benzinga
Analyst Ratings for 89bio
August 17, 2022
Within the last quarter, 89bio (NASDAQ:ETNB) has observed the following analyst ratings:
Via
Benzinga
Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday
September 14, 2022
Gainers Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX...
Via
Benzinga
US Stocks Open Lower After Inflation Report, Dow Dips 700 Points
September 13, 2022
U.S. stocks traded sharply lower this morning, following the release of inflation data for August
Via
Benzinga
6 Analysts Have This to Say About 89bio
August 17, 2022
Analysts have provided the following ratings for 89bio (NASDAQ:ETNB) within the last quarter:
Via
Benzinga
Where 89bio Stands With Analysts
August 17, 2022
Analysts have provided the following ratings for 89bio (NASDAQ:ETNB) within the last quarter:
Via
Benzinga
Why Amazon, Microsoft, Apple Shares Are Trading Lower, Here Are 50 Stocks Moving In Tuesday's Mid-Day Session
September 13, 2022
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 186% to $47.69 as the stock started trading on a 1-for-30 reverse split basis.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
September 13, 2022
Investors can start off the day with a breakdown of the biggest pre-market stock movers for Tuesday and the news moving those shares!
Via
InvestorPlace
Expert Ratings for 89bio
July 28, 2022
Analysts have provided the following ratings for 89bio (NASDAQ:ETNB) within the last quarter:
Via
Benzinga
This Analyst Thinks 89Bio's Pegozafermin Data Has Exceeded Expectations
July 11, 2022
Via
Benzinga
89bio Posts Promising Pegozafermin Data For Severe Hypertriglyceridemia
June 29, 2022
89bio Inc (NASDAQ: ETNB)
Via
Benzinga
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
August 26, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
August 26, 2022
Via
Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
August 18, 2022
Via
Benzinga
89bio Shares Climb After Concluding Enrolment In Mid-Stage NASH Study
August 18, 2022
89bio (NASDAQ: ETNB) has completed enrollment in ENLIVEN, the Phase 2b trial of pegozafermin for the treatment of non-alcoholic steatohepatitis (NASH).
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 17, 2022
Via
Benzinga
Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday
August 15, 2022
Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results.
Via
Benzinga
Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Day Session
August 12, 2022
Gainers Twin Vee Powercats Co. (NASDAQ: VEEE) shares jumped 90% to $7.60 after the company said Q2 sales results were up year over year.
Via
Benzinga
Recap: 89bio Q2 Earnings
August 11, 2022
89bio (NASDAQ:ETNB) reported its Q2 earnings results on Thursday, August 11, 2022. Here's what investors need to know about the announcement. Earnings 89bio missed estimated earnings by 14.95%,...
Via
Benzinga
The Daily Biotech Pulse: Merck's Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill
July 07, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Disney To $125? Here's The Biggest Price Target Changes For Thursday
June 30, 2022
Stifel cut SMART Global Holdings, Inc. (NASDAQ: SGH) price target from $45 to $32. SMART Global shares fell 13.1% to $17.62 in pre-market trading.
Via
Benzinga
5 Analysts Have This to Say About 89bio
June 29, 2022
Over the past 3 months, 5 analysts have published their opinion on 89bio (NASDAQ:ETNB) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's...
Via
Benzinga
The Daily Biotech Pulse: Eli Lilly Modifies COVID-19 Treatment Pact, Oyster Point Outlines Restructuring Plan, Icosavax Posts Interim RSV Vaccine Data
June 29, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
U.S. Stock Futures Edge Higher; GDP Report In Focus
June 29, 2022
Pre-open movers
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.